Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Metabolic Interventions in PAH

Cleveland Clinic Respiratory Institute

A. R Hemnes

Regulatory Pathways for Devices for Management of Pulmonary Embolism…

PERT Consortium 2021

S. Lossef

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ACC 2023: Clinical Manifestations of Right Ventricular Failure

ACC 2023 Conference Coverage

J. Huston

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

Pulmonary Arterial Hypertension: Update on Diagnosis and Management

Sandeep Sahay

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

The North American Thrombosis Forum (NATF)

G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong

Pericardiocentesis in Pulmonary Hypertension

Chao-Wei Hwang

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Scripps Health

R. C. Mohan

Interventions for PE in 2021: Papers You Need to Know

PERT Consortium 2021

J. Moriarty

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

ATS 2023 Insights

G. Heresi